was a good session today. great summary TravelBug
apart from the data points around VP-001 the market is trying to understand if PYC has an edge - what that edge is - how protected it is - and most importantly the value.
that edge has to be demonstrated across multiple dimensions
- pre-clinic
- clinic
- marketplace/patients ($ and demand in pharma outfield)
- repeatability/scalability (entity EV as a player in the industry)
am personally very excited but any analyst/fund manager as too look at complicated nuances across a matrix of factors and time horizons.
faithful & hopeful
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |